GZERO North
Graphic Truth: Obesity on the rise
Obesity and Ozempic use in the US and Canada
Paige Fusco
Obesity rates have risen strikingly since the 1990s in the US, according to a newstudy from The Lancet, with nearly three-quarters of the country overweight or obese — and more than 50% considered obese or severely obese. Obesity has also been on the rise in Canada, with 30% of adults considered obese in 2023.
Amidst skyrocketing obesity, usage of Ozempic — a drug that aids with weight loss by mimicking the “fullness” hormone in the brain and curbing appetite — has also been increasing, with prescriptions rising by 300% in the US between 2020-2022. As of 2023, 12% of adults in Canada use the drug, compared to 10% in the US. While usage levels are relatively similar in both countries, prices are drastically different, with the weight loss drug costing over $600 more per month in the US.
At the 2026 Paris Peace Forum, former Georgian President Salome Zourabichvili reflects on why Western democracies failed to respond more forcefully to Vladimir Putin’s efforts to expand Russian influence over neighboring countries and challenge European security, despite years of warning signs.
Ian Bremmer analyzes Paraguay's banking crisis.
As children face growing risks from social media, artificial intelligence, and other global challenges, France is calling for stronger international action to protect younger generations.
This week, a UK court overturned a law criminalizing homosexuality in Trinidad and Tobago.